Latest News and Press Releases

DUBLINO, Irlanda, 15 maggio 2009 (GLOBE NEWSWIRE) - Il dott. John Fox, di Merrion Pharmaceuticals ("Merrion" o la "Societa"), oggi parteciperà alla 7th International Cancer Conference a Dublino ed...

DUBLIN, Ireland, May 15, 2009 (GLOBE NEWSWIRE) -- Dr. John Fox, of Merrion Pharmaceuticals ("Merrion" or the "Company"), will address the 7th International Cancer Conference in Dublin today, and will...

DUBLIN, Ireland, May 15, 2009 (GLOBE NEWSWIRE) -- Dr. John Fox, of Merrion Pharmaceuticals ("Merrion" or the "Company"), will address the 7th International Cancer Conference in Dublin today, and...

DUBLIN, Ireland, Feb. 10, 2009 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals plc (IEX:MERR), an international specialty pharmaceutical development company, today announces the completion of patient...

DUBLIN, Ireland, Feb. 10, 2009 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals plc (IEX:MERR), an international specialty pharmaceutical development company, today announces the completion of patient...

Mymetics Corporation verkündet Erfolg ihres Präventivimpfstoffes gegen HIV/AIDS und Start der europäischen Phase 1 von menschlichen klinischen Studien NYON, Schweiz, 6. Feb. 2009 (GLOBE NEWSWIRE)...

Communiqué photo -- Merrion annonce la passation d'un contrat avec Novo Nordisk, visant à mettre au point une préparation orale de l'agoniste/des agonistes du récepteur GLP-1 -- Novo Nordisk...

Autorización para publicar fotografías -- Merrion anuncia acuerdo de licencia con Novo Nordisk para desarrollar fórmulas orales del agonista del receptor GLP-1(s) -- Novo Nordisk invierte en...

Edizione fotografica - Merrion dà annuncio dell'accordo di licenza con Novo Nordisk per lo sviluppo del composto orale agonista del recettore GLP-1 -- Novo Nordisk investe in azioni di Merrion...

DUBLIN, Irland, 19. Jan. 2009 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals (IEX:MERR) und Novo Nordisk A/S (NYSE:NVO), ein globaler Marktführer für Diabetes, haben einen Entwicklungs- und...